Bridgepoint Group (BPT) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
18 Jul, 2025Executive summary
Strong H1 2025 financial performance with €2.6bn returned to investors, robust fundraising, and full-year guidance reaffirmed.
AUM increased 20% year-over-year to $87bn, with fee-paying AUM at €37.5bn and management/other fees up 11%.
€8bn raised toward €24bn fundraising target by 2026, supported by product diversification and strong LP interest.
Interim dividend of 4.7p per share announced, with continued capital returns and new product launches underpinning growth.
Superior positioning in the European mid-market and robust pipeline of exits for H2 and into 2026.
Financial highlights
Management and other income (excluding catch-up fees) rose 11% year-over-year, surpassing £200m for the first time in a half year.
Fee-related earnings (FRE) of £76m with a 37% margin; underlying EBITDA £128m with a 48% margin.
PRE of £57.6m, representing ~22–25% of total income, with full-year guidance reaffirmed.
Net leverage at 1.3x 2025 consensus underlying EBITDA; available liquidity £354m.
Profit before tax was £60.6m, down from £99.9m year-over-year due to lower catch-up fees and higher exceptional costs.
Outlook and guidance
Full-year guidance reaffirmed; confident in raising €24bn by end of 2026, with €8bn already raised.
EBITDA margin expected at 52–55% for 2025/26; PRE to remain ~25% of total income.
High single-digit expense growth anticipated; BE VIII to become fee-paying mid-2026.
Positive outlook for portfolio company exits, with several planned for H2 2025 and 2026.
Latest events from Bridgepoint Group
- AUM rose 25% to $94.1bn, EBITDA margin hit 53%, and fundraising momentum was strong.BPT
H2 202512 Mar 2026 - Record H1 2024 growth, upgraded guidance, and ECP integration drive momentum.BPT
H1 20243 Feb 2026 - Aims to double AUM to $200bn in 5–6 years, expanding mid-market and private wealth strategies.BPT
CMD 202418 Jan 2026 - EBITDA up 96%, AUM up 80% to $75.6bn, and fundraising target raised to €24bn.BPT
H2 202421 Dec 2025